Advanced company searchLink opens in new window

CRISTAE THERAPEUTICS LIMITED

Company number 16281411

Filter by category

Filter by category


Confirmation statement filters, selecting an input will reload the page.
Confirmation statement filters, selecting an input will reload the page.

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
06 Nov 2026 SH20 Statement by Directors
This document is being processed and will be available in 10 days.
06 Nov 2026 CAP-SS Solvency Statement dated 02/11/26
This document is being processed and will be available in 10 days.
20 Oct 2026 MA Memorandum and Articles of Association
20 Oct 2026 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
20 Oct 2026 RESOLUTIONS Resolutions
  • RES13 ‐ Re: ratification of director's action 15/09/2026
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
  • RES01 ‐ Resolution of adoption of Articles of Association
14 Oct 2026 SH01 Statement of capital following an allotment of shares on 15 September 2026
  • USD 17,118,436
09 Oct 2026 SH01 Statement of capital following an allotment of shares on 18 August 2026
  • USD 12,845,889
08 Oct 2026 MA Memorandum and Articles of Association
22 Sep 2026 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
17 Aug 2026 RP01SH01 Replacement filing of SH01 - 20/01/26 Statement of Capital usd 11381232
29 Jun 2026 AA Micro company accounts made up to 31 December 2025
14 Apr 2026 TM01 Termination of appointment of Philippe Marinos Costeletos as a director on 23 February 2026
28 Mar 2026 MA Memorandum and Articles of Association
21 Mar 2026 AP01 Appointment of Mr Joshua Nabatian as a director on 10 September 2025
21 Mar 2026 AP01 Appointment of Mr Kammy Moalemzadeh as a director on 10 September 2025
20 Mar 2026 AP01 Appointment of Mr Agostino Barazza as a director on 10 September 2025
11 Mar 2026 CS01 Confirmation statement made on 26 February 2026 with updates
10 Mar 2026 AP01 Appointment of Dr Steven England as a director on 10 September 2025
10 Mar 2026 TM01 Termination of appointment of Steven England as a director on 10 September 2025
03 Mar 2026 PSC05 Change of details for Nzp Uk Limited as a person with significant control on 9 September 2025
11 Feb 2026 AP01 Appointment of Dr Niall O'donnell as a director on 10 September 2025
11 Feb 2026 AP01 Appointment of Mr Philippe Costeletos as a director on 15 October 2025
10 Feb 2026 AP01 Appointment of Mr Alessandro Barbieri as a director on 10 September 2025
21 Jan 2026 SH01 Statement of capital following an allotment of shares on 20 January 2026
  • USD 11,381,232
  • ANNOTATION Replaced a replacement SH01 was registered on 17/08/2026 as the original contained an error
13 Jan 2026 PSC05 Change of details for Nzp Uk Limited as a person with significant control on 13 January 2026